My Crossword Maker Logo
Powered by BrightSprout
Save Status:
or to save your progress. The page will not refresh.
Controls:
SPACEBAR SWITCHES TYPING DIRECTION
Answer Key:
Edit a Copy:
Make Your Own:
Crucigrama Sopa de Letras Hoja de Trabajo
Calificar este Puzzle:
Log in or sign up to rate this puzzle.

DAPA-CKD Journal Club

Horizontales
What was the composite primary outcome _____ that equaled 0.61?
19 was the ____ in the DAPA-CKD trial.
Where is DAPA-CKD published?
Investigators recommended that the trial be ____early because of clear efficacy.
The ____of regimen due to an adverse event was 5.5% vs. 5.7% for DAPA versus pbo respectively.
10 mg was the ____ of DAPA used in the DAPA-CKD trial.
This effect of DAPA on the primary outcome was generally _____ across pre-specified subgroups.
The ___ risk ratio of the composite primary endpoint would be 39%.
Verticales
Number of patients ____ in DAPA-CKD was 4304.
Which inclusion criteria was at or above 200 and at or below 5000 mg/g at 1st visit?
Decline of at or above 50% in eGFR, new ESRD, renal mortality or CVD mortality.
The markedly lower ____ in the DAPA group than in the pbo group supports the use of DAPA as an addition to the therapeutic management of CKD.
The benefit of SGLT2i appear to be ____ of their blood glucose-lowering effects.
Clinical question...What is the long-term efficacy and safety of DAPA in patients with ___ disease, with or without T2D?
14% of DAPA patients had an eGFR of <30 which is considered to be Stage 4 CKD or ___ loss?
Which inclusion criteria was at or above 25 and at or below 75 mL/min/1.73m squared?